City
Epaper

New blood test offers hope for early detection of Parkinson's disease

By IANS | Updated: April 12, 2025 12:21 IST

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before ...

Open in App

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before symptoms emerge.

Parkinson's is often diagnosed only after significant brain damage has occurred, when most relevant neurons are already lost, underscoring the need for early detection.

The new method, detailed in the journal Nature Aging, measures specific RNA fragments in the blood, Xinhua news agency reported.

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson's patients, and mitochondrial RNA -- which declines as the disease progresses, said the Hebrew University of Jerusalem (HU).

"This discovery represents a major advancement in our understanding of Parkinson's disease and offers a simple, minimally invasive blood test as a tool for early diagnosis," said Prof. Hermona Soreq from the varsity.

"By focusing on tRFs, we've opened a new window into the molecular changes that occur in the earliest stages of the disease."

In experiments, the test successfully distinguished pre-symptomatic Parkinson's patients from healthy controls with an accuracy of 86 per cent, outperforming current diagnostic methods.

Notably, the study also found that levels of the first type of fragments drop after deep brain stimulation, linking them to disease mechanisms and treatment responses.

The researchers said that this discovery paves the way for early interventions and treatments that could change the course of the disease, potentially improving patient outcomes through timely diagnosis and care.

Lead researcher Nimrod Madrer emphasised the importance of early detection, noting that Parkinson's disease is often diagnosed only after significant brain damage has occurred.

"This test has the potential to alleviate the uncertainty faced by patients and clinicians, offering a reliable and rapid method to identify the disease in its earliest stages," Madrer stated.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentVarun Dhawan misses ‘Sunny Sanskari Ki Tulsi Kumari’ shoot days, shares BTS pictures

BusinessNew freight, passenger trains enhance connectivity in northeast

NationalNew freight, passenger trains enhance connectivity in northeast

NationalKerala LoP Satheesan demands CBI probe into Sabarimala gold fiasco

EntertainmentAnshula Kapoor drops adorable pictures from Gor Dhana ceremony with Rohan Thakkar, brother Arjun Kapoor, father Boney Kapoor

Health Realted Stories

HealthMP orders blanket ban on toxic 'Coldrif' syrup sale, all quantities to be disposed immediately

HealthAfter nine paediatric deaths; MP bans 'lethal' cough syrup, urges TN govt to initiate probe

HealthOver 4.4 lakh chikungunya disease cases, 155 deaths reported worldwide in 2025: WHO

HealthLong Covid patients more likely to suffer from unusual heart rhythm disorder

HealthVenugopal calls on Kharge, wishes him speedy recovery